Page last updated: 2024-12-08

n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fenhexamid : An aromatic amide resulting from the formal condensation of the carboxy group of 1-methylcyclohexanecarboxylic acid with the amino group of 4-amino-2,3-dichlorophenol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID213031
CHEMBL ID1688541
CHEBI ID81853
SCHEMBL ID23092
MeSH IDM0419957

Synonyms (49)

Synonym
LS-14298
fenhexamid [iso:bsi]
teldor
elevate
cyclohexanecarboxamide, n-(2,3-dichloro-4-hydroxyphenyl)-1-methyl-
hsdb 7273
kbr 2738
NCGC00163791-01
126833-17-8
fenhexamid
n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide
NCGC00163791-02
kbr2738
kbr-2738
FT-0668488
CHEMBL1688541
chebi:81853 ,
n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexane-1-carboxamide
NCGC00163791-03
C18593
cas-126833-17-8
NCGC00254944-01
tox21_301042
dtxsid3032549 ,
dtxcid1012549
unii-q68c3c9p1u
q68c3c9p1u ,
decree
AKOS015903660
fenhexamid [iso]
fenhexamid [hsdb]
1-methyl-cyclohexanecarboxylic acid (2,3-dichloro-4-hydroxy-phenyl)-amide
2',3'-dichloro-4'-hydroxy-1-methylcyclohexanecarboxanilide
fenhexamid [mi]
SCHEMBL23092
fenhexamide
n-(2,3-dichloro-4-hydroxy-phenyl)-1-methyl-cyclohexanecarboxamide
VDLGAVXLJYLFDH-UHFFFAOYSA-N
J-005440
fenhexamid, pestanal(r), analytical standard
fenhexamid 10 microg/ml in cyclohexane
mfcd03095700
teldor; elevate;kbr 2738
F0967
Q63395375
AMY40772
T71668
HY-118065
CS-0065121
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
EC 1.14.13.72 (methylsterol monooxygenase) inhibitorAn EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of methylsterol monooxygenase (EC 1.14.13.72).
sterol biosynthesis inhibitorAny compound that inhibits the biosynthesis of any sterol.
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
monocarboxylic acid amideA carboxamide derived from a monocarboxylic acid.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
aromatic amideAn amide in which the amide linkage is bonded directly to an aromatic system.
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
anilide fungicideAny amide fungicide whose structure contains an anilide group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency28.70930.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency40.73760.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency24.33650.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency2.43370.001022.650876.6163AID1224838
progesterone receptorHomo sapiens (human)Potency27.30600.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency43.64120.000214.376460.0339AID720692
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency62.62240.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency27.47090.375827.485161.6524AID588527; AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency34.72490.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency53.56730.000229.305416,493.5996AID1259244; AID743069; AID743075; AID743077; AID743078; AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.06160.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency68.58960.001723.839378.1014AID743083
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency50.14480.057821.109761.2679AID1159526; AID1159528
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency33.63000.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency76.95880.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency68.58960.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency76.95880.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (121)

Assay IDTitleYearJournalArticle
AID582544Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 520a assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582540Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 440a assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582671Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg F412I mutant at 2 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112895Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae MDR to EC50 for wild type Oculimacula yallundae TriS by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112881Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 to EC50 for wild type Oculimacula yallundae TriS by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582666Antifungal activity against Botrytis cinerea B05.10 harboring TELerg F412S mutant assessed as appearance of mycelium growth up to 20 ug/ml2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582634Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-AVB assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582673Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg N369D mutant at 5 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582635Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-PV Reims assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582614Antifungal activity against highly fenhexamid-resistant Botrytis cinerea MK3-9 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582630Antifungal activity against fenhexamid-senistive Botrytis cinerea B05.10 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582653Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 05-ABA assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112893Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR2 to EC50 for wild type Oculimacula yallundae TriS by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582528Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-221 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112129Antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582641Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 264 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582626Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 453b assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582654Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 57 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112892Fungicidal activity against Oculimacula acuformis assessed as inhibition of germ tube elongation incubated at 19 degC in dark for 48 hr2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582538Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 379a assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112171Protective antifungal activity against Botryotinia fuckeliana inoculated in fungicide-applied strawberry fruit assessed as disease control efficacy at 100 ug AI/ml applied 48 hr prior inoculation relative to control2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID1112166Protective antifungal activity against Botryotinia fuckeliana inoculated in fungicide-applied strawberry fruit assessed as disease severity measuring lesion diameter at 100 ug AI/ml applied 24 hr prior inoculation2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID1112161Protective antifungal activity against Botryotinia fuckeliana inoculated in fungicide-applied strawberry fruit assessed as disease control efficacy at 100 ug AI/ml applied 24 hr prior inoculation relative to control2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582664Antifungal activity against Botrytis cinerea 223b expressing erg27 HydR3+ alleles assessed as appearance of dense mycelium up to 20 ug/ml2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582616Antifungal activity against highly fenhexamid-resistant Botrytis cinerea MK5-2 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582620Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 202 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112879Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR2 to EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582655Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 202 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582722Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg F412I mutant at 5 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582726Antifungal activity against Botrytis cinerea 286 harboring TELerg S336C mutant at 10 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582537Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 312 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112110Protective antifungal activity against Botryotinia fuckeliana inoculated in fungicide-applied strawberry fruit assessed as disease severity measuring lesion diameter at 100 ug AI/ml applied 96 hr prior-inoculation2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582669Antifungal activity against Botrytis cinerea 286 harboring TELerg S336C mutant at 1 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582624Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 452 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582534Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 223a assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582650Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 520b assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582638Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 214 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582628Antifungal activity against fenhexamid-senistive Botrytis cinerea SAS405 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582649Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 520a assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112882Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae MDR to EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112888Fungicidal activity against Oculimacula yallundae assessed as inhibition of mycelial growth in presence of 10 g glucose incubated at 19 degC in dark for 4 weeks2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582631Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 1837 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582660Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 453a assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582663Antifungal activity against Botrytis cinerea 1837 expressing erg27 HydR3+ alleles assessed as appearance of dense mycelium up to 20 ug/ml2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582526Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 1837 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582543Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 506b assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582545Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 520b assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582639Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 223a assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582536Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 264 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112877Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae MDR to EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582632Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-190 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112880Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR2 to EC50 for wild type Oculimacula yallundae TriS by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582533Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 214 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112156Curative antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit assessed as disease severity measuring lesion diameter at 100 ug AI/ml applied 48 hr post-inoculation2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582532Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 179 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112889Fungicidal activity against Oculimacula acuformis assessed as inhibition of mycelial growth in presence of 10 g glucose incubated at 19 degC in dark for 4 weeks2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID1112146Curative antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit assessed as disease severity measuring lesion diameter at 100 ug AI/ml applied 24 hr post-inoculation2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582524Antifungal activity against fenhexamid-senistive Botrytis cinerea SAS405 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582541Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 440b assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112131Curative antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit assessed as disease control efficacy at 100 ug AI/ml applied 96 hr post-inoculation relative to control2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582670Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg N369D mutant at 2 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582647Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 506a assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582640Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 223b assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582648Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 506b assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582657Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 286 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112141Curative antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit assessed as disease control efficacy at 100 ug AI/ml applied 24 hr post-inoculation relative to control2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582643Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 379a assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582621Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 221 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582542Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 506a assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582549Antifungal activity against highly fenhexamid-resistant Botrytis cinerea MK3-36 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582668Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg F412I mutant at 1 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582539Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 379b assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112885Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 to EC50 for wild type Oculimacula yallundae TriS by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582546Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 533 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582652Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 05-1.27 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112887Selectivity index, ratio of EC50 for Oculimacula acuformis to EC50 for Oculimacula yallundae in presence of 10 g glucose by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582659Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 452 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582658Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 365 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582623Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 365 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582642Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 312 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582724Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg N369D mutant at 10 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582525Antifungal activity against fenhexamid-senistive Botrytis cinerea B05.10 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582615Antifungal activity against highly fenhexamid-resistant Botrytis cinerea MK5-14 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582618Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 05-ABA assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582633Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-221 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582723Antifungal activity against Botrytis cinerea 286 harboring TELerg S336C mutant at 5 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582547Antifungal activity against highly fenhexamid-resistant Botrytis cinerea MK3-1 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582535Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 223b assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582531Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 118 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582629Antifungal activity against fenhexamid-senistive Botrytis cinerea SAS56 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582627Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 454 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112176Protective antifungal activity against Botryotinia fuckeliana inoculated in fungicide-applied strawberry fruit assessed as disease severity measuring lesion diameter at 100 ug AI/ml applied 48 hr prior inoculation2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582625Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 453a assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112181Protective antifungal activity against Botryotinia fuckeliana inoculated in fungicide-applied strawberry fruit assessed as disease control efficacy at 100 ug AI/ml applied 96 hr prior-inoculation relative to control2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582523Antifungal activity against fenhexamid-senistive Botrytis cinerea SAS56 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582665Antifungal activity against Botrytis cinerea B05.10 harboring TELerg F412I mutant assessed as appearance of mycelium growth up to 20 ug/ml2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582667Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg N369D mutant at 1 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582527Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-190 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582617Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 05-1.27 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582646Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 440b assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112894Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR2 to EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae TriR1 by mycelial growth inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582622Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 286 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582619Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 57 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582662Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 454 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112890Selectivity index, ratio of EC50 for Oculimacula acuformis to EC50 for Oculimacula yallundae by germ tube elongation inhibition assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582725Antifungal activity against HydR3 deficient Botrytis cinerea 453 harboring TELerg F412I mutant at 10 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582672Antifungal activity against Botrytis cinerea 286 harboring TELerg S336C mutant at 2 ug/ml relative to wild-type2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112136Curative antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit assessed as disease severity measuring lesion diameter at 100 ug AI/ml applied 96 hr post-inoculation2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582661Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 453b assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112151Curative antifungal activity against Botryotinia fuckeliana inoculated in strawberry fruit assessed as disease control efficacy at 100 ug AI/ml applied 48 hr post-inoculation relative to control2012Pest management science, Jun, Volume: 68, Issue:6
Biological activity of the succinate dehydrogenase inhibitor fluopyram against Botrytis cinerea and fungal baseline sensitivity.
AID582656Antifungal activity against moderately to slightly fenhexamid-resistant Botrytis cinerea 221 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112891Fungicidal activity against Oculimacula yallundae assessed as inhibition of germ tube elongation incubated at 19 degC in dark for 48 hr2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582529Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-AVB assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582644Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 379b assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582636Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 118 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582645Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 440a assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID1112878Resistance index, ratio of EC50 for sterol 14alpha-demethylation inhibitor-resistant Oculimacula yallundae MDR to EC50 for wild type Oculimacula yallundae TriS by germ tube elongation assay2013Pest management science, Jan, Volume: 69, Issue:1
Fungicide resistance status in French populations of the wheat eyespot fungi Oculimacula acuformis and Oculimacula yallundae.
AID582637Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 179 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582530Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 05-PV Reims assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582651Antifungal activity against highly fenhexamid-resistant Botrytis cinerea 533 assessed as inhibition of mycelium growth measured over 5 days2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
AID582548Antifungal activity against highly fenhexamid-resistant Botrytis cinerea MK3-31 assessed as inhibition of germ tube elongation after 24 hrs2008Antimicrobial agents and chemotherapy, Nov, Volume: 52, Issue:11
Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's18 (38.30)29.6817
2010's25 (53.19)24.3611
2020's4 (8.51)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.71 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.08%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (97.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]